Botswana Vaccine Institute (BVI)

Botswana Vaccine Institute LTD was established in 1979 as an autonomous and totally self-financing company wholly owned by the Government of Botswana (GoB). Since its establishment, BVI has forged a strong technical cooperation with Merial (the animal health division of Sanofi), a leader in the research, manufacture and supply of livestock vaccines. BVI was initially established to produce FMD vaccines to provide biological safeguards to ensure Botswana's livestock industry freedom against FMD and to maintain exports of animals and animal products worldwide which was the key export earner before discovery of minerals.

 

However, over the years BVI has extended its mandate to produce other livestock vaccines including Foot and Mouth Disease vaccines-FMD, Contagious Bovine Pleuropneumonia Vaccine -CBPP, Peste des Petits Ruminants Vaccine-PPR, Anthrax vaccine and Quarter Evil/Blackquater vaccine.

 

VISION

BVI is committed to be the leader in the production of quality livestock vaccines.

MISSION

To support livestock industry by manufacturing relevant vaccines and providing services of the highest quality through utilization of the best technology, skilled and dedicated employees to combat economically devastating livestock diseases.

Through a network of partnerships, ehance adherence of sound manufacturing and environmentally friendly processes and remain sustainable.